Bristol-Myers Squibb Executive Murdo Gordon Set to Depart

Murdo Gordon, chief commercial officer of Bristol-Myers Squibb (NYSE: [[ticker:BMY]]), is leaving. The New York-based pharmaceutical giant announced Monday that Gordon would depart on Aug. 3 “to pursue another opportunity.” No other details were given. According to a securities filing, Gordon notified the company of his plans on July 17. Before starting as Bristol’s chief commercial officer in 2016, Gordon held several executive roles at the company including senior vice president of oncology and immunology, and president of U.S. pharmaceuticals. Bristol said an announcement regarding Gordon’s successor would be made at a later date.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan